CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Mariana Oncology
Mariana Oncology logo

Mariana Oncology

Mariana Oncology: A next-gen radiopharmaceutical firm specializing in solid tumor treatment.

Watertown, MA, US🇺🇸
Founded
2021
Overview
Compare
Fundraising
Employees

Mariana Oncology is a next-generation radiopharmaceutical company focused on developing treatments for solid tumors. By integrating expertise in ligand discovery, radiochemistry, radiobiology, and oncology research, the company aims to build a robust pipeline of innovative therapies. Their mission is to advance the field of radiopharmaceuticals to improve outcomes for cancer patients.

Mariana Oncology has made significant strides in the radiopharmaceutical industry, contributing to advancements in cancer treatment. The company collaborates with leading experts to push the boundaries of current oncology therapies, aiming for impactful clinical results.

Mariana Oncology - Similar Companies

Radionetics Oncology logo

Radionetics Oncology

radionetics.com

Aktis Oncology logo

Aktis Oncology

aktisoncology.com

Illumina Radiopharmaceuticals logo

Illumina Radiopharmaceuticals

Nucleus RadioPharma logo

Nucleus RadioPharma

nucleusrad.com

Oncurie logo

Oncurie

oncurie.com

Radiomedix logo

Radiomedix

radiomedix.com

Artbio logo

Artbio

artbio.com

Mira Oncology logo

Mira Oncology

NuView Life Sciences logo

NuView Life Sciences

Trevarx Biomedical logo

Trevarx Biomedical

trevarx.com

Ratio Therapeutics logo

Ratio Therapeutics

ratiotx.com

Lumiphore logo

Lumiphore

lumiphore.com

Sabik Medical logo

Sabik Medical

Core Oncology logo

Core Oncology

Cullinan Oncology logo

Cullinan Oncology

Mariana Oncology - Quick Facts

Who are Mariana Oncology's competitors?

Companies similar to Mariana Oncology include Radionetics Oncology, Aktis Oncology, Illumina Radiopharmaceuticals and Nucleus RadioPharma.

When was Mariana Oncology founded?

Mariana Oncology was founded in 2021.

Where is Mariana Oncology's headquarters located?

Mariana Oncology's headquarters is located in Watertown, MA, US.

When was Mariana Oncology's last funding round?

Mariana Oncology's most recent funding round was for $175M (USD) in September 2023.

How much disclosed funding has Mariana Oncology raised?

As of Sep 7, 2023, Mariana Oncology has disclosed funding of $250M (USD). Undisclosed round amounts are excluded.

How many employees does Mariana Oncology have?

Mariana Oncology has 32 employees as of Feb 4, 2024.

Mariana Oncology - Classification

Ownership
  • Private
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Radiopharmaceuticals
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software